Facing the patent expiration of Celebrex, the pharmaceutical industry is being active to get generic approvals
Generics of the nonsteroidal type anti-inflammatoryanalgesic drug, Celebrex (generic name: celecoxib), are preparing to launch in the market as its patent expiration is coming soon in this June.
According to the weekly state of approvals by the Ministry of Food and Drug Safety, 7 celecoxib-type ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
